Qantas Airways and China Eastern Airlines have announced the withdrawal of their joint business application with the Australian Competition and Consumer Commission (ACCC), marking the end of a long-standing partnership. This decision follows the ACCC’s recent plans to dissolve the partnership between the two airlines due to concerns about reduced competition and potential airfare hikes.
The partnership had facilitated coordinated passenger and cargo operations between Australia and China for the two carriers. In a statement, Qantas stated, “The airlines have commenced a process to unwind the joint business over the coming weeks, which includes an end to the coordination of pricing and schedules, and the removal of joint marketing material.”
The ACCC acknowledged the announcement, confirming that the interim authorization granted on March 30, 2023, is no longer in effect.
Read more: Australia: China pressures ACCC to Qantas-China Eastern deal
This move by Qantas follows its recent decision to abandon its A$611 million plan to acquire charter flight operator Alliance Aviation Services, which was blocked by the ACCC. Last week, the Australian government revealed plans to ask the ACCC to monitor domestic passenger flights in an effort to enhance competition in an industry largely dominated by Qantas, which has faced allegations of anti-competitive behavior.
In previous incidents, the ACCC had sued Qantas in August for selling tickets to thousands of flights that were canceled, exposing the company to potential substantial fines. This led to the early retirement of the long-serving CEO, Alan Joyce.
In a bid to restore investor trust and mend its tarnished reputation, Qantas recently announced that Chairman Richard Goyder would step down in late 2024 as part of a broader effort to renew the company’s board.
Source: Investing
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI